Condensed Consolidated Statements of Stockholders’ Deficit (Equity) (Unaudited) - USD ($) $ in Thousands	Common Stock Class A	Treasury Stock	Additional Paid-in- Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022			$ 153,939	$ (147,231)	$ 6,708
Balance (in Shares) at Dec. 31, 2022	2,966.987	(214,077)
Net loss				(7,639)	(7,639)
Stock based compensation			901		901
Stock based compensation (in Shares)	(11,100)
Balance at Mar. 31, 2023			154,840	(154,870)	(30)
Balance (in Shares) at Mar. 31, 2023	2,955,887	(214,077)
Balance at Dec. 31, 2023	$ 1		162,959	(177,060)	(14,100)
Balance (in Shares) at Dec. 31, 2023	7,646,032
Net loss				(2,160)	(2,160)
Deemed dividend from trigger of down round provisions and extension of Assumed Warrants			656		656
Shares issued under KR8 License Agreement			378		378
Shares issued under KR8 License Agreement (in Shares)	1,300,000
Shares issued under Corporate Development and Advisory Agreement			153		153
Shares issued under Corporate Development and Advisory Agreement (in Shares)	450,000
Shares issued to MSK under Shares for Services Agreement
Shares issued to MSK under Shares for Services Agreement (in Shares)	511,027
Warrants issued for finder’s fees			17		17
Shares issued to employee			16		16
Shares issued to employee (in Shares)	53,202
Stock based compensation			103		103
Stock based compensation (in Shares)	(667)
Balance at Mar. 31, 2024	$ 1		$ 164,382	$ (179,220)	$ (14,937)
Balance (in Shares) at Mar. 31, 2024	9,959,594